Špela Gubič
no.: 53671

researcher – not employed in research organisation

spela.gubic at sign

ffa.uni-lj.si

Research activity

Code	Science	Field	Subfield
1.09.00	Natural sciences and mathematics	Pharmacy

Bibliography Representative bibliographic units | Personal | COBISS+

Evaluation (metodology)

Points

64.38

A''

16.94

46.18

A1/2

54.73

CI10

CImax

h10

0.25

Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024

Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )

Database	Linked records	Citations	Pure citations	Average pure citations
WoS	4	50	45	11.25
Scopus	4	51	46	11.5

Education

Level of education	Professional title	Study subject	Faculty	Year
2nd cycle master's degree	B. Sc.		University of Ljubljana, Faculty of Pharmacy	2019

Doctoral dissertations and other final papers Show

Research projects Legend

no.	Code	Title	Period	Head	No. of publications
1.	J7-4635	MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy	10/1/2022 - 9/30/2026	PhD Lucija Peterlin Mašič	6,640
2.	J1-3030	MTAvsAMR: new MultiTargeting Antibiotics against AntiMicrobial Resistance	10/1/2021 - 9/30/2025	PhD Lucija Peterlin Mašič	1,070
3.	L3-3177	Safety evaluation of cannabidiols and implications for public health and consumers behaviour	10/1/2021 - 12/31/2024	PhD Alja Štern	5,119
4.	N1-0098	Discovery and mechanism of action of novel hEag1 potassium channel lead molecules with anti-cancer activity	1/1/2019 - 12/31/2022	PhD Lucija Peterlin Mašič	979
5.	J1-9192	New anticancer leads for emerging cancer target potassium ion channels hEag1 and its validation in lymphoma tumors	7/1/2018 - 6/30/2021	PhD Lucija Peterlin Mašič	2,420
6.	J1-8152	Inhibicija prenove celične stene Staphylococus aureus (Slovene)	5/1/2017 - 4/30/2020	PhD Dušan Turk	2,155